Abstract: The present invention relates to the novel topical composition of arthritis emulgel. The present invention specifically relates to novel topical composition of arthritis emulgel comprising combination of active ingredients and pharmaceutically acceptable excipients. The present invention more specifically relates to novel composition of arthritis emulgel comprising combination of Curcumin (using Force C3™ augmented absorption technology), Boswellia serrata extract, Methyl salicylate, Menthol as active ingredients and pharmaceutically acceptable excipients. The present invention more specifically relates to novel composition, wherein composition optionally contains one or more of Ginger extract, Glucosamine sulphate and Chondroitin sulphate. The present invention also relates to process for the preparation of novel topical composition of arthritis emulgel comprising the steps of dissolving, mixing, adding, sonicating, adjusting the pH and stirring.

Abstract: The present invention relates to the novel extended release multiple unit pellet system composition and process for the preparation. The present invention specifically relates to novel extended release multiple unit pellet system composition comprising active pharmaceutical ingredient and pharmaceutically acceptable excipients. The present invention also relates to novel dispersible extended release multiple unit pellet system composition comprising active pharmaceutical ingredient and pharmaceutically acceptable excipients, wherein the active pharmaceutical ingredient is present in the core spheres. The present invention more specifically relates to novel process for the preparation of extended release multiple unit pellet system composition using dual seal coating technology.

Abstract: The present invention relates to extended-release suspension composition. The present invention specifically relates to extended-release suspension composition comprising active ingredient and pharmaceutically acceptable excipients, wherein said composition is in the form of powder for suspension or a ready to use suspension. The present invention specifically relates to extended-release suspension composition comprising active ingredient and pharmaceutically acceptable excipients, wherein said composition is devoid of uncoated active ingredient-ion exchange resin complex portion and polyvinyl acetate. The present invention also relates to extended-release suspension composition comprising one or more functional barrier coatings on active ingredient-ion exchange resin complex, wherein said functional barrier coatings comprises hypromellose and/or talc.

Abstract: The present invention relates to Rapid melt granules prepared by encapsulation and complexation processes. The present invention specifically relates to Rapid melt granules prepared by novel process of particulate coating comprising the steps of encapsulation of active ingredient with encapsulation polymer and/or pore former, drying, blending, optionally polymer coating, drying before blending and filling into sachets or compressing into tablets. The present invention more specifically relates to Rapid melt granules prepared by novel process of complexation comprising the steps of complexation of active ingredient with sulfonated polymers of ion exchange resin, drying, blending, optionally polymer coating, drying before blending and filling into sachets or compressing into tablets.

Abstract: Embodiments relate to a formulation comprising a particle comprising a turmeric oleoresin or a curcumin removed turmeric oleoresin or a turmeric oil or combination thereof wherein the composition is water-soluble and therapeutically safe, wherein the composition does not contain a pH buffer, and wherein the composition further comprises a curcuminoid.